Renal Function Dips in First Year After Bladder Cancer Trimodal Therapy
Trimodal therapy for bladder cancer results in a slight decline in eGFR in the first year but stabilizes thereafter for up to 10 years, a study found.
Jody A. Charnow
Editor
Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.
